Ascend Wellness Holdings (XCNQ:AAWH.U) Debt-to-EBITDA : 8.84 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Ascend Wellness Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ascend Wellness Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $14.8 Mil. Ascend Wellness Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $558.7 Mil. Ascend Wellness Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was $64.9 Mil. Ascend Wellness Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 8.84.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ascend Wellness Holdings's Debt-to-EBITDA or its related term are showing as below:

XCNQ:AAWH.U' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -65535.14 Med: 12.18 Max: 19.22
Current: 6.97

During the past 5 years, the highest Debt-to-EBITDA Ratio of Ascend Wellness Holdings was 19.22. The lowest was -65535.14. And the median was 12.18.

XCNQ:AAWH.U's Debt-to-EBITDA is ranked worse than
87.58% of 660 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs XCNQ:AAWH.U: 6.97

Ascend Wellness Holdings Debt-to-EBITDA Historical Data

The historical data trend for Ascend Wellness Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascend Wellness Holdings Debt-to-EBITDA Chart

Ascend Wellness Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

17.39

-65,535.14

19.22

6.97

Ascend Wellness Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial												8.27	6.27	6.06	7.29	8.84

Competitive Comparison of Ascend Wellness Holdings's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ascend Wellness Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascend Wellness Holdings's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascend Wellness Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ascend Wellness Holdings's Debt-to-EBITDA falls into.

Ascend Wellness Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ascend Wellness Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(14.808	+	558.652)	/	82.26
	=	6.97

Ascend Wellness Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(14.808	+	558.652)	/	64.852
	=	8.84

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Ascend Wellness Holdings (XCNQ:AAWH.U) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Ascend Wellness Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ascend Wellness Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascend Wellness Holdings (XCNQ:AAWH.U) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascend Wellness Holdings Inc (XCNQ:AAWH.U) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

AAWH:USA

Address

1411 Broadway, 16th Floor, New York, NY, USA, 10018

Website

https://www.awholdings.com

Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited license markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.

Ascend Wellness Holdings (XCNQ:AAWH.U) Headlines

No Headlines